These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 8665523

  • 1. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
    Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK.
    Cancer Res; 1996 Jun 15; 56(12):2837-43. PubMed ID: 8665523
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ.
    J Cell Physiol; 1991 Oct 15; 149(1):34-43. PubMed ID: 1834680
    [Abstract] [Full Text] [Related]

  • 3. Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.
    Mars WM, Jo M, Gonias SL.
    Biochem J; 2005 Aug 15; 390(Pt 1):311-5. PubMed ID: 15869463
    [Abstract] [Full Text] [Related]

  • 4. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G, D'Alessio S, Pucci M, Cerletti M, Del Rosso M.
    Biol Chem; 2002 Jan 15; 383(1):127-36. PubMed ID: 11928807
    [Abstract] [Full Text] [Related]

  • 5. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 15; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 6. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
    Piedagnel R, Tiger Y, Lelongt B, Ronco PM.
    J Cell Physiol; 2006 Feb 15; 206(2):394-401. PubMed ID: 16155905
    [Abstract] [Full Text] [Related]

  • 7. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE, Blasi F, Rifkin DB.
    J Cell Physiol; 1994 Mar 15; 158(3):398-407. PubMed ID: 8126064
    [Abstract] [Full Text] [Related]

  • 8. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM, Grenett HE, Benza RL, Abou-Agag LH, Tresnak JK, Wheeler CG, Booyse FM.
    Alcohol Clin Exp Res; 2001 Feb 15; 25(2):163-70. PubMed ID: 11236828
    [Abstract] [Full Text] [Related]

  • 9. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May 15; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
    Yee JA, Yan L, Dominguez JC, Allan EH, Martin TJ.
    J Cell Physiol; 1993 Dec 15; 157(3):528-34. PubMed ID: 8253864
    [Abstract] [Full Text] [Related]

  • 11. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.
    Int J Oncol; 2005 Jul 15; 27(1):223-35. PubMed ID: 15942664
    [Abstract] [Full Text] [Related]

  • 12. Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro.
    Sato Y, Okamura K, Morimoto A, Hamanaka R, Hamaguchi K, Shimada T, Ono M, Kohno K, Sakata T, Kuwano M.
    Exp Cell Res; 1993 Feb 15; 204(2):223-9. PubMed ID: 7679996
    [Abstract] [Full Text] [Related]

  • 13. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC, Merlino G, Cveklova K, Mosinger B, Fausto N.
    Cancer Res; 1994 Nov 15; 54(22):5964-73. PubMed ID: 7525051
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R.
    J Cell Physiol; 1989 Jul 15; 140(1):119-30. PubMed ID: 2500450
    [Abstract] [Full Text] [Related]

  • 15. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
    Pepper MS, Rosnoblet C, Di Sanza C, Kruithof EK.
    Thromb Haemost; 2001 Aug 15; 86(2):702-9. PubMed ID: 11522025
    [Abstract] [Full Text] [Related]

  • 16. Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells.
    Wilson HM, Reid FJ, Brown PA, Power DA, Haites NE, Booth NA.
    Exp Nephrol; 1993 Aug 15; 1(6):343-50. PubMed ID: 8081986
    [Abstract] [Full Text] [Related]

  • 17. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
    Fibbi G, Pucci M, Grappone C, Pellegrini G, Salzano R, Casini A, Milani S, Del Rosso M.
    Hepatology; 1999 Mar 15; 29(3):868-78. PubMed ID: 10051491
    [Abstract] [Full Text] [Related]

  • 18. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
    Stolz DB, Michalopoulos GK.
    J Cell Physiol; 1997 Jan 15; 170(1):57-68. PubMed ID: 9012785
    [Abstract] [Full Text] [Related]

  • 19. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
    De Petro G, Copeta A, Barlati S.
    Exp Cell Res; 1994 Jul 15; 213(1):286-94. PubMed ID: 8020601
    [Abstract] [Full Text] [Related]

  • 20. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
    De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S.
    Cancer Res; 1998 May 15; 58(10):2234-9. PubMed ID: 9605771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.